576 related articles for article (PubMed ID: 16528626)
21. The effect of percutaneous ethanol injection therapy on small solitary hepatocellular carcinoma is comparable to that of hepatectomy.
Kotoh K; Sakai H; Sakamoto S; Nakayama S; Satoh M; Morotomi I; Nawata H
Am J Gastroenterol; 1994 Feb; 89(2):194-8. PubMed ID: 8304302
[TBL] [Abstract][Full Text] [Related]
22. Comparison of therapeutic effects between radiofrequency ablation and percutaneous microwave coagulation therapy for small hepatocellular carcinomas.
Ohmoto K; Yoshioka N; Tomiyama Y; Shibata N; Kawase T; Yoshida K; Kuboki M; Yamamoto S
J Gastroenterol Hepatol; 2009 Feb; 24(2):223-7. PubMed ID: 18823439
[TBL] [Abstract][Full Text] [Related]
23. [Complete response (CR) in a case of advanced hepatocellular carcinoma by percutaneous multi-ablation therapy].
Ishihara K; Beppu T; Ishiko T; Iwagami S; Doi K; Hirota M; Yamashita Y; Ogawa M
Gan To Kagaku Ryoho; 2001 Oct; 28(11):1791-4. PubMed ID: 11708036
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of laparoscopic radiofrequency ablation for hepatocellular carcinoma compared to percutaneous radiofrequency ablation with artificial ascites.
Hirooka M; Kisaka Y; Uehara T; Ishida K; Kumagi T; Watanabe Y; Abe M; Matsuura B; Hiasa Y; Onji M
Dig Endosc; 2009 Apr; 21(2):82-6. PubMed ID: 19691779
[TBL] [Abstract][Full Text] [Related]
25. Combined percutaneous radiofrequency ablation and ethanol injection of renal tumours: midterm results.
Fotiadis NI; Sabharwal T; Morales JP; Hodgson DJ; O'Brien TS; Adam A
Eur Urol; 2007 Sep; 52(3):777-84. PubMed ID: 17400364
[TBL] [Abstract][Full Text] [Related]
26. Local ablation therapy for hepatocellular carcinoma. From ethanol injection to radiofrequency ablation.
Shiina S; Tateishi R; Yoshida H; Kanai F; Omata M
Saudi Med J; 2007 Jun; 28(6):831-7. PubMed ID: 17530094
[TBL] [Abstract][Full Text] [Related]
27. [Combined treatment of hepatocarcinoma with chemoembolization and alcohol administration. Long-term results].
Bartolozzi C; Lencioni R; Armillotta N
Radiol Med; 1997; 94(1-2):19-23. PubMed ID: 9424645
[TBL] [Abstract][Full Text] [Related]
28. Combination therapy of percutaneous ethanol injection and radiofrequency ablation against hepatocellular carcinomas difficult to treat.
Kurokohchi K; Watanabe S; Masaki T; Hosomi N; Funaki T; Arima K; Yoshida S; Nakai S; Murota M; Miyauchi Y; Kuriyama S
Int J Oncol; 2002 Sep; 21(3):611-5. PubMed ID: 12168107
[TBL] [Abstract][Full Text] [Related]
29. Radiofrequency ablation of hepatocellular carcinoma in cirrhotic patients.
Guglielmi A; Ruzzenente A; Battocchia A; Tonon A; Fracastoro G; Cordiano C
Hepatogastroenterology; 2003; 50(50):480-4. PubMed ID: 12749252
[TBL] [Abstract][Full Text] [Related]
30. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases.
Tateishi R; Shiina S; Teratani T; Obi S; Sato S; Koike Y; Fujishima T; Yoshida H; Kawabe T; Omata M
Cancer; 2005 Mar; 103(6):1201-9. PubMed ID: 15690326
[TBL] [Abstract][Full Text] [Related]
31. A critical appraisal of the literature on local ablative therapies for hepatocellular carcinoma.
Lencioni R; Crocetti L
Clin Liver Dis; 2005 May; 9(2):301-14, viii. PubMed ID: 15831275
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of hepatocellular carcinoma locoregional therapies on patients waiting for liver transplantation.
Moreno Planas JM; López Monclús J; Gómez Cruz A; Rubio González E; Pérez Arangüena R; Boullosa Graña E; Garcia Suárez A; Pérez-Picouto JL; Fernández Ruiz M; Lucena de la Poza JL; Sánchez Turrión V; Cuervas-Mons Martínez V
Transplant Proc; 2005 Apr; 37(3):1484-5. PubMed ID: 15866648
[TBL] [Abstract][Full Text] [Related]
33. Prospective histopathological analysis of hepatocellular carcinoma treated with percutaneous ethanol injection in patients on the waiting list for liver transplantation.
Castroagudin JF; Delgado M; Martinez SM; Abdulkader I; Potel J; Tome S; Otero E; Varo E
Transplant Proc; 2005 Apr; 37(3):1477-9. PubMed ID: 15866645
[TBL] [Abstract][Full Text] [Related]
34. [Surgical resection versus percutaneous thermal ablation for early-stage hepatocellular carcinoma: a randomized clinical trial].
Lü MD; Kuang M; Liang LJ; Xie XY; Peng BG; Liu GJ; Li DM; Lai JM; Li SQ
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(12):801-5. PubMed ID: 16681964
[TBL] [Abstract][Full Text] [Related]
35. Pilot study of combination therapy with transcatheter arterial infusion chemotherapy using iodized oil and percutaneous radiofrequency ablation during occlusion of hepatic blood flow for hepatocellular carcinoma.
Shiraishi R; Yamasaki T; Saeki I; Okita K; Yamaguchi Y; Uchida K; Terai S; Sakaida I
Am J Clin Oncol; 2008 Aug; 31(4):311-6. PubMed ID: 18845987
[TBL] [Abstract][Full Text] [Related]
36. Vascular endothelial growth factor monitoring in advanced hepatocellular carcinoma patients treated with radiofrequency ablation plus octreotide: a single center experience.
Montella L; Addeo R; Caraglia M; Faiola V; Guarrasi R; Vincenzi B; Palmeri A; Capasso E; Nocera V; Tarantino L; Ariete M; Martorelli A; Del Prete S
Oncol Rep; 2008 Aug; 20(2):385-90. PubMed ID: 18636202
[TBL] [Abstract][Full Text] [Related]
37. [Radiofrequency ablation of hepatocellular carcinoma in patients with cirrhosis].
Bonny C; Abergel A; Gayard P; Chouzet S; Ughetto S; Slim K; Rosenfeld L; Guillon R; Poincloux L; Bommelaer G
Gastroenterol Clin Biol; 2002; 26(8-9):735-41. PubMed ID: 12434078
[TBL] [Abstract][Full Text] [Related]
38. Local ablative therapies in HCC: percutaneous ethanol injection and radiofrequency ablation.
Mahnken AH; Bruners P; Günther RW
Dig Dis; 2009; 27(2):148-56. PubMed ID: 19546553
[TBL] [Abstract][Full Text] [Related]
39. Risk factors of survival after percutaneous radiofrequency ablation of hepatocellular carcinoma.
Peng ZW; Zhang YJ; Chen MS; Liang HH; Li JQ; Zhang YQ; Lau WY
Surg Oncol; 2008 Jul; 17(1):23-31. PubMed ID: 17869095
[TBL] [Abstract][Full Text] [Related]
40. Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study.
Yamagiwa K; Shiraki K; Yamakado K; Mizuno S; Hori T; Yagi S; Hamada T; Iida T; Nakamura I; Fujii K; Usui M; Isaji S; Ito K; Tagawa S; Takeda K; Yokoi H; Noguchi T
J Gastroenterol Hepatol; 2008 Mar; 23(3):482-90. PubMed ID: 18086115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
